NEOG - NEOGEN CORP

9.7
-0.990   -10.206%

Share volume: 2,564,208
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$10.69
-0.99
-0.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
52%
Profitability 44%
Dept financing 27%
Liquidity 60%
Performance 64%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-13.00%
1 Month
-8.58%
3 Months
60.60%
6 Months
71.38%
1 Year
-6.73%
2 Year
-42.12%
Key data
Stock price
$9.70
P/E Ratio 
0.00
DAY RANGE
$9.64 - $10.67
EPS 
-$2.05
52 WEEK RANGE
$3.87 - $11.42
52 WEEK CHANGE
-$2.81
MARKET CAP 
1.299 B
YIELD 
N/A
SHARES OUTSTANDING 
217.526 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-29-2025
BETA 
1.31
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,048,346
AVERAGE 30 VOLUME 
$3,074,147
Company detail
CEO: John E. Adent
Region: US
Website: neogen.com
Employees: 2,110
IPO year: 1994
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Neogen Corporation develops, manufactures, and markets various products for food and animal safety worldwide. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides.

Recent news